TASS

Sekisui Diagnostics, LLC Enters Strategic Partnership with Qualigen Inc.

- Sekisui Diagnostics to expand point of care testing portfolio with the FastPack® IP System from Qualigen Inc. - Qualigen expands their commercial reach through relationship with Sekisui Diagnostics ...
Nasdaq

Qualigen Therapeutics Releases FastPack® SARS-CoV-2 Antibody Diagnostic Test to University of Louisville to Conduct Validation Studies

CARLSBAD, Calif., June 2, 2020 /PRNewswire/ -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (Qualigen or the Company) announced today that the Company has released a pre-launch supply of its proposed ...
technologynetworks

Sekisui Diagnostics Expands Point of Care Diagnostics

Sekisui Diagnostics has significantly expanded its point of care (POC) diagnostics product line through a recent partnership agreement with Qualigen, Inc. Sekisui Diagnostics is now the exclusive ...
Business Insider

Qualigen Therapeutics Submits Notification to FDA to Commence Distribution of its FastPack® COVID-19 Antibody Test

CARLSBAD, Calif., July 1, 2020 /PRNewswire/ -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) ("Qualigen" or the "Company") announces it has submitted an official notification to the U.S. Food and Drug ...
Business Insider

Qualigen Receives FDA Clearance for its FastPack® IP SHBG Assay

CARLSBAD, Calif., Jan. 29, 2019 /PRNewswire/ -- Qualigen, Inc., a privately-owned company that provides novel diagnostic and therapeutic technologies for the treatment of cancer and infectious ...